Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Whitman

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Cancer Research|February 24, 2001
The partial nontandem duplication of the MLL (ALL1) gene is a novel rearrangement that generates three distinct fusion transcripts in B-cell acute lymphoblastic leukemiaS P Whitman, M P Strout, G Marcucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B StudyGuido Marcucci, Kati Maharry, Susan P Whitman, et al.
Biochemistry|May 21, 2021
Kinetic and Structural Analysis of Two Linkers in the Tautomerase Superfamily: Analysis and ImplicationsBert-Jan Baas, Brenda P Medellin, Jake A LeVieux, et al.
Blood|May 4, 2006
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B studyMichael D Radmacher, Guido Marcucci, Amy S Ruppert, et al.
Cancer Research|May 3, 2008
Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemiaBjörn Hackanson, Kristi L Bennett, Romulo M Brena, et al.
Blood|June 21, 2008
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplicationSusan P Whitman, Björn Hackanson, Sandya Liyanarachchi, et al.
Cancer Research|October 5, 2001
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B studyS P Whitman, K J Archer, L Feng, et al.
Blood|March 8, 2007
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B studySusan P Whitman, Amy S Ruppert, Guido Marcucci, et al.
Blood|October 18, 2007
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplicationsSusan P Whitman, Amy S Ruppert, Michael D Radmacher, et al.
Cancer Research|March 1, 2005
Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemiaShujun Liu, Tiansheng Shen, Lenguyen Huynh, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Cancer Research|February 24, 2001
The partial nontandem duplication of the MLL (ALL1) gene is a novel rearrangement that generates three distinct fusion transcripts in B-cell acute lymphoblastic leukemiaS P Whitman, M P Strout, G Marcucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B StudyGuido Marcucci, Kati Maharry, Susan P Whitman, et al.
Biochemistry|May 21, 2021
Kinetic and Structural Analysis of Two Linkers in the Tautomerase Superfamily: Analysis and ImplicationsBert-Jan Baas, Brenda P Medellin, Jake A LeVieux, et al.
Blood|May 4, 2006
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B studyMichael D Radmacher, Guido Marcucci, Amy S Ruppert, et al.
Cancer Research|May 3, 2008
Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemiaBjörn Hackanson, Kristi L Bennett, Romulo M Brena, et al.
Blood|June 21, 2008
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplicationSusan P Whitman, Björn Hackanson, Sandya Liyanarachchi, et al.
Cancer Research|October 5, 2001
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B studyS P Whitman, K J Archer, L Feng, et al.
Blood|March 8, 2007
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B studySusan P Whitman, Amy S Ruppert, Guido Marcucci, et al.
Blood|October 18, 2007
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplicationsSusan P Whitman, Amy S Ruppert, Michael D Radmacher, et al.
Cancer Research|March 1, 2005
Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemiaShujun Liu, Tiansheng Shen, Lenguyen Huynh, et al.
Pageof 17